Juno Therapeutics | search
Click here to view Juno Therapeutics news from 60+ newspapers.
Bookmark or Share- Juno Therapeutics - WikipediaWebsite. www .bms .com. Juno Therapeutics Inc was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
- Celgene confirms $9B Juno buyout, sees $3B sales for JCAR017Celgene has agreed to buy CAR-T specialist Juno Therapeutics for around $9 billion in a deal that instantly makes it a big cheese in this emerging therapeutic category. The definitive terms...
- Celgene Corporation to Acquire Juno Therapeutics, Inc.Juno is a pioneer in the development of CAR (chimeric antigen receptor) T and TCR (T cell receptor) therapeutics with a broad, novel portfolio evaluating multiple targets and cancer indications.
- Juno's lasting legacy: How the cell therapy juggernaut ... - GeekWireWhen Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune...
- FDA Approves Fourth CAR-T Cell Therapy (Breyanzi) to Juno TherapeuticsFDA Approves Breyanzi to Juno Therapeutics, a BMS Company. Breyanzi i s the U.S. FDA’s fourth approval of a CAR-T cell therapy, which now include: Kymriah. Yescarta. Tecartus. Breyanzi. It is also the first regenerative medicine therapy with RMAT designation to be licensed by the FDA.
More
